Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.53 USD | +1.25% | -7.65% | +39.65% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.65% | 2.15B | |
+29.11% | 49.18B | |
+0.95% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.29% | 26.09B | |
-22.68% | 18.71B | |
+8.11% | 13.26B | |
+32.04% | 12.32B | |
-0.47% | 11.99B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Wells Fargo Ups Price Target on Kymera Therapeutics to $42 From $40, Maintains Overweight Rating